Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Time Is Main Barrier to SLE Quality Indicators

Clin Rheumatol; ePub 2016 Nov 22; Casey, et al

Rheumatologists had a positive perception of the systemic lupus erythematosus (SLE) quality indicators and agreed that use of the quality indicators could improve quality of care in SLE, according to a recent study. Using a cross-sectional survey of rheumatologists in the southeastern US, researchers assessed the perception and involvement of rheumatologists in quality improvement and the SLE quality indicators. Using electronic mail, an online survey of 32 questions was delivered to 568 rheumatologists. With a response rate of 19% (n=106), the majority of participants were male, Caucasian, with more than 20 years of experience, and seeing adult patients in an academic setting. They found:

  • Participants had a positive perception toward quality improvement (81%) with a majority responding that the SLE quality indicators would significantly impact quality of care (54%).
  • While 66% of respondents were familiar with the SLE quality indicators, only 18% of respondents reported using them in everyday practice.
  • The most commonly reported barrier to involvement in quality improvement and the SLE quality indicators was time.

Casey C, Chung CP, Crofford LJ, Barnado A. Rheumatologists’ perception of systemic lupus erythematosus quality indicators: Significant interest and perceived barriers. [Published online ahead of print November 22, 2016]. Clin Rheumatol. doi:10.1007/s10067-016-3487-3.         

This Week's Must Reads

No Association Between Fiber Intake and Bone Loss, J Bone Miner Res; ePub 2017 Nov 7; Dai, Zhang, et al

Geographic Distance Affects DMARD Use for Veterans, J Rheumatol; ePub 2017 Nov 15; Walsh, Pei, et al

Patient-Physician Assessments and Quality of Life , RMD Open; ePub 2017 Oct 25; Karpouzas, et al

Recent Fractures Linked with Lower BMD in Women, J Bone Miner Res; ePub 2017 Nov 8; Rozental, et al

Non-Surgical OA Treatment Factors Evaluated, Arthritis Care Res; ePub Nov 10; Abbate, et al

Must Reads in Lupus & Connective Tissue Diseases

Study: Premature Mortality Rates in SLE Unchanged, Rheumatology (Oxford); ePub 2017 Nov 7; Jorge, et al

46-Year Trends in SLE Mortality in the US, Ann Intern Med; ePub 2017 Oct 31; Yen, et al

LupusPRO v1.8: Acceptable Reliability, Validity , Lupus; ePub 2017 Oct 31; Azizoddin, et al

Lung Tissue Inflammation in SLE Cause for Concern, Lupus Sci Med; 2017 ePub 2017 Oct 23; Ryu, et al

Exploring Link Between CV and Rheumatic Diseases, Clin Rheumatol; ePub 2017 Oct 9; Jafri, Ogdie, et al